title: Long-term results of OKT3-treated renal transplant recipients.
authors.affiliation: Department of Urology and Surgery, Kidney Center, Tokyo Women's Medical College, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Sonda
authors.forename: T
authors.initials: T
authors.lastname: Tokumoto
authors.forename: S
authors.initials: S
authors.lastname: Koga
authors.forename: H
authors.initials: H
authors.lastname: Nakazawa
authors.forename: N
authors.initials: N
authors.lastname: Goya
authors.forename: T
authors.initials: T
authors.lastname: Yagisawa
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: T
authors.initials: T
authors.lastname: Kawai
authors.forename: H
authors.initials: H
authors.lastname: Toma
authors.forename: K
authors.initials: K
authors.lastname: Ota
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003404:Creatinine